| 20-1119 |
Amarin Pharma, Inc., et al. v. Hikma Pharmaceuticals USA Inc., et al. |
Federal Circuit |
2021-02-16 |
Denied |
Amici (3)Response RequestedResponse WaivedRelisted (2) |
35-usc-103 graham-factors graham-v-john-deere hindsight-bias innovation innovation-protection nonobviousness-indicia objective-indicia obviousness-standard patent patent-law |
Whether a court must consider objective indicia of nonobviousness together with the other factors bearing on an obviousness challenge before making an… |
| 20-158 |
SRAM, LLC v. FOX Factory, Inc. |
Federal Circuit |
2020-08-13 |
Denied |
Response Waived |
35-usc-103 commercial-success federal-circuit graham-v-john-deere nonobviousness objective-indicia patent-act patent-claim patent-law person-of-ordinary-skill secondary-considerations statutory-interpretation |
Whether the Federal Circuit erred in holding that, under 35 U.S.C. § 103, before a nexus can be presumed between objective indicia of nonobviousness a… |
| 18-1289 |
Allergan, Inc., et al. v. Teva Pharmaceuticals USA, Inc., et al. |
Federal Circuit |
2019-04-10 |
Denied |
Response Waived |
blocking-patent blocking-patent-doctrine commercial-success graham-v-john-deere long-felt-need objective-indicia objective-indicia-of-non-obviousness obviousness patent-law patent-law-doctrine-of-obviousness prior-art |
Whether the Federal Circuit erred in holding that objective indicia of non-obviousness may be partially or entirely discounted where the development o… |
| 18-1280 |
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., et al. |
Federal Circuit |
2019-04-08 |
Denied |
Amici (5) |
blocking-patent-doctrine blocking-patents burden-of-proof graham-v-john-deere nonobviousness objective-indicia obviousness patent patent-law patent-obviousness pharmaceutical-innovation prior-art |
Whether objective indicia of nonobviousness may be partially or entirely discounted where the development of the invention was allegedly 'blocked' by … |